Nieuws
Bernstein-analisten handhaafden dinsdag hun positieve vooruitzichten voor aandelen van Eli Lilly (NYSE: LLY) en bevestigden ...
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
9d
Stocktwits on MSNMerck, Pfizer, Eli Lilly Stocks Rebound As Trump Targets Drug Costs With New Executive OrderPfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President ...
• What Eli Lilly’s chief executive said about Trump’s plans to repatriate supply chains to America • The scale of Lilly’s ...
Gehost op MSN10d
Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders WaryThe discontinuation rate due to side effects was 6.1% for Zepbound and 8% for Wegovy. On Stocktwits, sentiment toward Eli ...
Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
Ireland has become a major base for US pharma companies, including Pfizer, Eli Lilly and Johnson & Johnson. That’s bolstered the economies of individual towns and played a role in the country’s ...
President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...
the latest drugmaker to expand its presence in the United States amid President Donald Trump's tariff policies. Boards, Policy & Regulationcategory· May 12, 2025 Eli Lilly's Zepbound outperforms ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...
Sommige resultaten zijn verborgen omdat ze mogelijk niet toegankelijk zijn voor u.
Niet-toegankelijke resultaten weergeven